We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
14 hedge funds and large institutions have $36.5M invested in ESSA Pharma in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
90% more capital invested
Capital invested by funds: $19.2M → $36.5M (+$17.2M)
17% more funds holding
Funds holding: 12 → 14 (+2)
Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.37%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
4
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$8.87M |
| 2 |
CV
Clarus Ventures
Cambridge,
Massachusetts
|
+$6.92M |
| 3 |
AIC
AWM Investment Company
New York
|
+$3.16M |
| 4 |
DM
Deerfield Management
New York
|
+$2.37M |
| 5 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$1.98M |
